The Combination of Octreotide and Midodrine Is Not Superior to Albumin in Preventing Recurrence of Ascites After Large-Volume Paracentesis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 10, 2012, Pages 1169-1175

  Bari, Khurram ^a,b   Miñano, Cecilia ^a,b   Shea, Martha ^b   Inayat, Irteza B ^a,b   Hashem, Hashem J ^a,b   Gilles, HoChong ^c   Heuman, Douglas ^c   Garcia Tsao, Guadalupe ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

Author keywords

Circulatory Dysfunction; Cirrhosis; Randomized Clinical Trial; Renal Failure

Indexed keywords

ALBUMIN; CREATININE; MIDODRINE; OCTREOTIDE; SODIUM;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DOUBLE BLIND PROCEDURE; EDEMA; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HEADACHE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARACENTESIS; POSTOPERATIVE COMPLICATION; POSTPARACENTESIS CIRCULATORY DYSFUNCTION; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; STOMACH DISEASE; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; UREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASCITES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDODRINE; OCTREOTIDE; PARACENTESIS; PLACEBOS; PROSPECTIVE STUDIES; RECURRENCE; SERUM ALBUMIN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84866437969     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.06.027     Document Type: Article

References (17)

1. Arroyo V., Ginès P., Gerbes A.L., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996, 23:164-176.
2. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010, 53:397-417. European Association for the Study of the Liver.
3. Ginès A., Fernández-Esparrach G., Monescillo A., et al. Randomized trial comparing albumin, dextran 70 and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996, 111:1002-1010.
4. Ruiz-del-Arbol L., Monescillo A., Jimenéz W., et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997, 113:579-586.
5. Sola-Vera J., Miñana J., Ricart E., et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003, 37:1147-1153.
6. Moreau R., Asselah T., Condat B., et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 2002, 50:90-94.
7. Singh V., Kumar R., Nain C.K., et al. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol 2006, 21:303-307.
8. Lata J., Marecek Z., Fejfar T., et al. The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites-a randomized multicentric study. Hepatogastroenterology 2007, 54:1930-1933.
9. Moore K.P., Wong F., Gines P., et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003, 38:258-266.
10. Thomsen T.W., Shaffer R.W., White B., et al. Videos in clinical medicine. Paracentesis. N Engl J Med 2006, 355:e21.
11. Salerno F., Gerbes A., Ginès P., et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. A consensus workshop of the International Ascites Club. Gut 2007, 56:1310-1318.
12. Ginès P., Uriz J., Calahorra B., et al. Transjugular intrahepatic portosystemic shunting versus repeated paracentesis plus albumin for refractory ascites in cirrhosis: a multicenter randomized comparative study. Gastroenterology 2002, 123:1839-1847.
13. Appenrodt B., Wolf A., Grünhage F., et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008, 28:1019-1025.
14. Angeli P., Volpin R., Gerunda G., et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999, 29:1690-1697.
15. Singh V., Dheerendra P.C., Singh B., et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol 2008, 103:1399-1405.
16. Tandon P., Tsuyuki R.T., Mitchell L., et al. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study. Liver Int 2009, 29:169-174.
17. Bernardi M., Caraceni P., Navickis R.J., et al. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 2012, 55:1172-1181.